Late Breaking Clinical Trials 1 PCI, FFR and cost

[LB1-3] Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry

^○Kuramitsu Shoichi¹, Ohya Masanobu², Shinozaki Tomohiro³, Otake Hiromasa⁴, Horie Kazunori⁵, Kawamoto Hiroyoshi⁶, Yamanaka Futoshi⁷, Natsuaki Masahiro⁸, Shiomi Hiroki⁹, Nakazawa Gaku¹⁰, Ando Kenji¹, Kadota Kazushige², Saito Shigeru⁷, Kimura Takeshi⁹ (1.Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan, 2.Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan (M.O., K.K.), 3.Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan, 4.Division of Cardiology, Department of Internal Medicine, Kobe University Graduates School of Medicine, Kobe, Japan, 5.Department of Cardiovascular Medicine, Sendai Kousei Hospital, Sendai, Japan, 6.Department of Cardiology, New Tokyo Hospital, Chiba, Japan, 7.Division of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital, Kanagawa, Japan, 8.Department of Cardiology, Saiseikai Fukuoka General Hospital, Fukuoka Japan, 9.Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 10.Division of Cardiology, Tokai University School of Medicine, Isehara, Japan)

同通あり